Ghost Tree Capital, LLC Adverum Biotechnologies, Inc. Transaction History

Ghost Tree Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$9.84 - $14.26 $11.4 Million - $16.6 Million	-1,161,375 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.3 - $21.64 $2.69 Million - $5.66 Million	261,375 Added 29.04%	1,161,375 $12 Million
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $3.46 Million - $10.4 Million	-405,500 Reduced 31.06%	900,000 $18.8 Million
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $1.04 Million - $2.13 Million	130,500 Added 11.11%	1,305,500 $12.8 Million
Q4 2019 Feb 14, 2020	SELL	$5.12 - $12.22 $1.41 Million - $3.36 Million	-275,000 Reduced 18.97%	1,175,000 $13.5 Million
Q3 2019 Nov 14, 2019	BUY	$5.24 - $15.89 $7.6 Million - $23 Million	1,450,000 New	1,450,000 $7.9 Million

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $681M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.